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Background: Oxidative stress has been implicated in the development of type 2 diabetes mellitus. Bilirubin is a
potent endogenous antioxidant, and coffee is a major source of exogenous antioxidants. Serum
gamma-glutamyltransferase (GGT), a marker of oxidative stress, is a strong predictor of the risk of type 2 diabetes
mellitus. This study evaluated the effect modification of bilirubin and coffee consumption on the association of
serum GGT with glycated hemoglobin (HbA1c) and the combined effect of bilirubin and coffee on HbA1c
concentrations.
Methods: The subjects were 4492 men and 6242 women aged 49–76 years who participated in the baseline
survey of an on-going cohort study on lifestyle-related diseases in Fukuoka, Japan. Geometric means of HbA1c were
examined according to quartile categories of GGT, with stratification by serum total bilirubin (≥ 0.6 mg/dL versus
less in men and ≥ 0.5 mg/dL versus less in women) and coffee consumption (< 1, 1–3 and ≥ 4 cups of per day).
Statistical adjustment was made for age, smoking, alcohol use and body mass index by using analysis of covariance.
Results: HbA1 concentrations increased progressively with increasing levels of GGT in both men and women. The
increasing trend of HbA1c concentrations associated with GGT did not differ by either bilirubin status or coffee
consumption. Both men and women with high bilirubin had consistently lower concentrations of HbA1c across the
GGT quartiles. Higher coffee consumption was associated with lower concentrations of HbA1c in women with low
bilirubin (trend P = 0.04), but not with high bilirubin (trend P = 0.37). There was no such association between
coffee and HbA1c in men with either low or high bilirubin levels.
Conclusions: Bilirubin is possibly protective against deterioration of glucose metabolism. Further studies are
needed regarding the combined effect of bilirubin and coffee on glucose metabolism.* Correspondence: skono@phealth.med.kyushu-u.ac.jp
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Oxidative stress has been implicated in the development
of type 2 diabetes mellitus [1,2]. In vitro and animal
studies showed that antioxidants improved insulin sensi-
tivity and were protective against beta-cell injury [3,4].
Bilirubin, the end product of heme catabolism, is a
potent endogenous antioxidant [5-7]. Enhancement of
bilirubin formation by induction of heme oxygenase-1
ameliorated glucose metabolism and insulin sensitivity
in rodents [8,9]. High bilirubin concentrations were
inversely related to the prevalence of type 2 diabetes
mellitus [10,11] and of the metabolic syndrome [12]. On
the other hand, coffee is a major source of exogenous
antioxidants in populations in which coffee is commonly
consumed [13-15]. Coffee drinking has consistently been
shown to be protective against type 2 diabetes mellitus
and glucose intolerance [16,17].
Elevated activities of serum gamma-glutamyltransferase
(GGT) are shown to be a strong predictor of type 2 dia-
betes mellitus independent of obesity index [18]. While
hepatic steatosis associated with visceral adiposity may
be a common mediator for elevated GGT and insulin re-
sistance [19], GGT may be a marker of oxidative stress
[20,21]. GGT is a plasma membrane enzyme involved in
the so-called gamma-glutamyl cycle by which extracel-
lular glutathione is transported into cells for the synthesis
of intracellular glutathione. Depletion of intracellular
antioxidant glutathione in response to oxidative stress
results in an increase in GGT so that the redox regulation
is maintained. Interestingly, it was shown that a decreased
risk of type 2 diabetes associated with coffee consumption
was more pronounced in individuals with elevated activ-
ities of serum GGT [22]. It is thus hypothesized that a
protective effect of antioxidants against type 2 diabetes
mellitus or glucose metabolism may depend on the mag-
nitude of the background oxidative stress.
In the study reported here, we evaluated the effect
modification of serum bilirubin and coffee intake on the
association between GGT and glycated hemoglobin
(HbA1c) in Japanese men and women. The combined ef-
fect of bilirubin and coffee on HbA1c concentrations was
a matter of another interest.Methods
Study subjects
The subjects were participants in the baseline survey
of an on-going cohort study on lifestyle-related dis-
eases. The study was approved by the Ethics Committee
of the Faculty of Medical Sciences, Kyushu University.
All the subjects gave written informed consent. A detailed
description of the baseline survey has been provided
elsewhere [10]. Briefly, residents aged 50–74 years in
the East Ward of Fukuoka City were invited to thesurvey by mail, and a total of 12948 persons partici-
pated in the survey from February 2004 to August
2007, with a participation rate of 24%. Age at the sur-
vey ranged 49 to 76 years; three women aged 49 years
were included because of a mistake in recording the
date of birth.
Stored serum for the measurement of serum bilirubin
was available for 12942 participants. We excluded 2195
subjects for the following reasons: medication for diabetes
mellitus (n = 680); current medical care for coronary ar-
tery diseases (n = 533), stroke (n = 276), cancer (n = 496)
or chronic hepatitis or cirrhosis (n = 232); prior history
of myocardial infarction or coronary angioplasty (n = 40)
or stroke (n = 152); aspartate aminotransferase (AST) or
alanine aminotransferase (ALT) greater than 3-fold of
the upper limit of the normal range, i.e., >120 U/L
(n = 59); GGT greater than 3-fold of the upper limit of
the normal range, i.e., > 450 U/L (n = 43); total bilirubin
> 3.0 mg/dL (n = 3); and serum creatinine > 2.0 mg/dL
(n = 44). The cutoff values for liver enzymes, bilirubin
and creatinine were defined arbitrarily, but were aimed
to exclude those with pathological conditions which
possibly affected lifestyle factors and/or glucose metab-
olism. Further excluded were 13 subjects who had miss-
ing values for liver enzymes, creatinine, alcohol use or
body mass index. Finally, 10734 subjects (4492 men and
6242 women) remained in the present analysis.Laboratory measurements
Non-fasting or fasting venous blood samples were taken
for the determination of HbA1c and serum bilirubin con-
centrations. Only 470 subjects (4.4%) had been fasting
for 10 hours or longer. Serum was separated by centrifu-
gation on the same day and frozen at −80°C. Whole-blood
samples for the measurement of HbA1c were transported
to an external laboratory (SRL, Tokyo) on the next work-
ing day after a temporary storage in refrigerator. HbA1c
was determined by using the latex agglutination immuno-
assay [23]. Total bilirubin concentrations were measured
at the above-described laboratory by the absorptiometric
assay with oxidation by vanadic acid [24]. Regarding
serum GGT, AST, ALT, creatinine and other 4 biochem-
ical measurements, recorded information was referred to
at the survey if they had been determined within the past
one year. Otherwise, 5 mL of venous blood was taken,
and the measurements were carried out at the same
laboratory as described above. The recorded measure-
ments were available for 3924 subjects (36.6%), and the
measurements were done at the survey for the remaining
6810 (63.4%). In the former group, 3191 (81.3%) reported
that the measurements was done after an overnight fast;
319 (4.7%) in the latter were in a fast of 10 hours or
longer at the survey.
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Dietary and non-dietary lifestyle factors, diseases under
medical treatment, history of selected diseases and other
factors were assessed by a self-administered question-
naire with supplementary interview. The food frequency
questionnaire developed by Tokudome et al. [25] was
modified with respect to alcohol and beverage consump-
tion. Alcohol users were defined as those who had con-
sumed alcoholic beverages at least once per week over a
period of one year or more, and former alcohol drinkers
were distinguished from lifelong abstainers. Current al-
cohol drinkers reported consumption frequencies and
amounts of five types of alcoholic beverages on average
over the past year. Likewise, habitual consumption over
the past one year was ascertained regarding coffee and
other beverages, by using closed-ended questions with
eight options (none, 1–2, 3–4 or 5–6 cups per week and
1–3, 4–6, 7–9 or ≥10 cups per day). Smokers were
defined as those who had smoked one or more cigarettes
per day for at least one year, and former smokers were
separated from life-long non-smokers. Former and
current smokers reported the average number of cigar-
ettes smoked per day and the total number of years of
smoking.Table 1 Selected characteristics of the study subjects by
sexAnthropometric measurements
Height (cm) and weight (kg) were measured, and body
mass index was calculated as weight divided by the




Age (year), mean (SD) 62.3 (6.8) 61.9 (6.7)
Body mass index (kg/m2),
mean (SD)




< 20 9.2 3.7
≥ 20 23.3 2.4
Alcohol use (mL/day), %
Never 21.1 70.4
Former 5.9 2.4
< 30 29.6 23.5
30–59 26.2 3.0
≥ 60 17.1 0.8
Daily use of coffee, % 57.5 58.0
Serum GGT (IU/L), median (IQR) 35 (24–58) 20 (16–29)
Serum total bilirubin (mg/dL),
median (IQR)
0.5 (0.4–0.7) 0.5 (0.4–0.6)
HbA1c (%), median (IQR) 5.0 (4.8–5.3) 5.1 (4.8–5.3)
GGT, gamma-glutamyl transferase; IQR, interquartile range; SD, standard
deviation.Statistical analysis
All analyses were performed in men and women separ-
ately. GGT levels were categorized by using sex-specific
quartiles. Individuals were classified into high (≥ 0.6 mg/dl
in men and ≥ 0.5 mg/dl in women) and low bilirubin
groups. These cutoff points appeared to be a threshold
in the sex-specific relationship with HbA1c levels [10],
and corresponded to the gender-wise medians. Coffee
consumption was categorized into < 1, 1–3 and ≥ 4 cups
of coffee per day. The following covariates were always
taken into account: age (continuous), smoking (never,
past and current smoking with a consumption of < 20
or ≥ 20 cigarettes/day), alcohol drinking (never, past
and current drinking with a consumption < 30, 30–59
or ≥ 60 mL of ethanol/day) and body mass index (sex-
specific quartiles). Trends of the associations of GGT
levels and coffee consumption with HbA1c were evalu-
ated by assigning ordinal values to GGT and coffee cat-
egories. Effect modification of bilirubin or coffee on the
association between GGT and HbA1c was evaluated by
using a product term of the ordinal variable for GGT and
a variable for bilirubin (dichotomous) or coffee (three
categories). Statistical significance was declared if two-sided P was less than 0.05. Statistical analyses were per-
formed by SAS version 9.2 (SAS Institute, Cary, NC).
Results
Selected characteristics of the study subjects are sum-
marized in Table 1. Women had lower values of body
mass index and GGT than men. Bilirubin concentrations
were slightly lower in women than in men, as indicated
by a lower value of the upper quartile while HbA1c
levels were higher in women. Geometric means of
HbA1c increased progressively with increasing levels of
GGT in both men and women. In men, age-adjusted
geometric means of HbA1c (%) for the quartile categories
of GGT (≤ 23, 24–35, 36–58 and ≥ 59 IU/L) were 5.00,
5.08, 5.16 and 5.20 respectively (trend P < 10–15), and
multivariate-adjusted geometric means were 4.99, 5.07,
5.16 and 5.23 respectively (trend P < 10–18). In women,
age-adjusted geometric means of HbA1c (%) accord-
ing to the quartile categories (≤ 15, 16–20, 21–29
and ≥ 30 IU/L) were 5.00, 5.06, 5.13 and 5.17 respectively
(trend P < 10–32), and multivariate-adjusted geometric
means were 5.00, 5.07, 5.12 and 5.16 respectively
(trend P < 10–26).
The increasing trend of HbA1c concentrations asso-
ciated with GGT did not differ by either bilirubin status
or coffee consumption (Table 2). Both men and women
Table 2 Adjusted geometric means of HbA1c for quartiles of gamma-glutamyltransferase (GGT) by bilirubin and coffee
consumption*
GGT† Trend Interaction
Stratification n Q1 (lowest) Q2 Q3 Q4 (highest) P‡ P
Men
Bilirubin (mg/dL)
Low (< 0.6) 2313 5.02 (4.97–5.07) 5.11 (5.06–5.16) 5.21 (5.16–5.26) 5.26 (5.20–5.31) < 10–9 0.72
High (≥ 0.6) 2179 4.95 (4.89–5.00) 5.02 (4.97–5.07) 5.12 (5.07–5.17) 5.20 (5.15–5.25) < 10–10
Coffee (cups/day)
< 1 1911 5.00 (4.95–5.06) 5.07 (5.02–5.13) 5.14 (5.09–5.20) 5.24 (5.18–5.29) < 10–6 0.64
1–3 2036 4.96 (4.91–5.01) 5.05 (5.00–5.10) 5.16 (5.11–5.21) 5.20 (5.14–5.26) < 10–9
≥ 4 545 5.03 (4.94–5.12) 5.13 (5.03–5.23) 5.27 (5.17–5.37) 5.32 (5.19–5.45) < 10–3
Women
Bilirubin (mg/dL)
Low (< 0.5) 2910 5.02 (4.99–5.05) 5.10 (5.07–5.13) 5.18 (5.15–5.21) 5.19 (5.16–5.22) < 10–16 0.22
High (≥ 0.5) 3332 4.99 (4.96–5.02) 5.03 (5.01–5.06) 5.07 (5.04–5.10) 5.14 (5.11–5.17) < 10–12
Coffee (cups/day)
< 1 2623 5.02 (4.99–5.06) 5.06 (5.03–5.10) 5.12 (5.09–5.15) 5.17 (5.14–5.20) < 10–9 0.86
1–3 3081 4.99 (4.96–5.02) 5.07 (5.05–5.10) 5.13 (5.10–5.16) 5.15 (5.12–5.18) < 10–15
≥ 4 538 4.99 (4.93–5.06) 5.02 (4.95–5.09) 5.08 (5.01–5.15) 5.17 (5.09–5.24) < 10–3
In parentheses are 95% confidence intervals of geometric means.
* Adjusted for age, smoking, alcohol intake and body mass index by analysis of covariance.
† The first to the fourth quartile (Q1 to Q4) categories were ≤ 23, 24–35, 36–58 and ≥ 59 IU/L in men; and ≤ 15, 16–20, 21–29 and ≥ 30 IU/L in women.
‡ Ordinal values were assigned to GGT categories.
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of HbA1c across the GGT quartiles. With adjustment
for GGT (quartile category) and the other covariates, the
geometric means of HbA1c (%) for the low and high bili-
rubin levels were 5.15 (95% CI 5.12–5.17) and 5.07
(95% CI 5.05–5.10) respectively in men (P < 10–4), and
5.12 (95% CI 5.11–5.14) and 5.06 (95% CI 5.04–5.07)
respectively in women (P < 10–9). The adjusted geomet-
ric means of HbA1c for coffee categories of < 1, 1–3 and
≥ 4 cups per day were 5.11 (95% CI 5.08–5.14), 5.09
(95% CI 5.07–5.12) and 5.18 (95% CI 5.13–5.24) respect-
ively in men (trend P = 0.20) and 5.09 (95% CI 5.08–
5.11), 5.09 (95% CI 5.07–5.10) and 5.06 (95% CI 5.03–
5.10) respectively in women (trend P = 0.18).
HbA1c concentrations according to the combination
of bilirubin and coffee use are shown in Table 3. High
bilirubin was consistently associated with lower concen-
trations of HbA1c regardless of coffee consumption except
for men consuming ≥ 4 cups of coffee per day. Higher cof-
fee consumption was associated with lower concentrations
of HbA1c in women with low bilirubin (trend P = 0.04),
but not with high bilirubin (trend P = 0.37), while the
interaction between bilirubin and coffee was far from
the statistical significance. In men, HbA1c concentrations
tended to be lower only among those consuming 1–3
cups of coffee per day. Serum GGT was weakly posi-
tively correlated with bilirubin concentrations in men(Spearman r = 0.099), and there was no correlation be-
tween the two in women (Spearman r = −0.004). With
further adjustment for GGT (quartile category), the
results for the combined categories of bilirubin and
coffee did not change appreciably, while the decreasing
trend of HbA1c with coffee consumption in women with
low bilirubin failed to reach the statistical significance
(trend P = 0.06).
Discussion
Expectedly, GGT levels were strongly, positively asso-
ciated with HbA1c concentrations in both men and
women. The present study showed no effect modification
of either bilirubin or coffee consumption on the associ-
ation between GGT and HbA1c. High bilirubin was con-
sistently associated with lower HbA1c concentrations
regardless of GGT levels.
The inverse association between serum bilirubin and
HbA1c itself is not a novel finding [10,11]. We previ-
ously reported an inverse association between bilirubin
and HbA1c in the present study population [10]. It was
also shown among dyslipidemic patients that bilirubin
concentrations were lower and serum GGT was higher in
patients with the metabolic syndrome as compared with
those without [12]. Nonetheless, it is notable that HbA1c
was consistently lowered in those with high bilirubin
across GGT levels. A cross-sectional inverse association
Table 3 Adjusted geometric means of HbA1c according to combined categories of bilirubin and coffee consumption*
Low bilirubin† High bilirubin†
Sex Coffee (cups/day) n Geometric mean n Geometric mean
Men < 1 877 5.16 (5.12–5.21) 1034 5.08 (5.05–5.12)
1–3 1077 5.13 (5.09–5.16) 959 5.04 (5.01–5.08)
≥ 4 359 5.16 (5.10–5.23) 186 5.18 (5.10–5.27)
Trend‡ P = 0.74 P = 0.55
Women < 1 1125 5.14 (5.12–5.17) 1498 5.06 (5.04–5.08)
1–3 1503 5.11 (5.09–5.13) 1578 5.06 (5.04–5.08)
≥ 4 282 5.09 (5.04–5.14) 256 5.02 (4.97–5.07)
Trend‡ P = 0.04 P = 0.37
In parentheses are 95% confidence intervals of geometric means. Interaction P values were 0.43 in men and 0.37 in women.
* Adjusted for age, smoking, alcohol intake and body mass index by analysis of covariance.
† Low: < 0.6 mg/dL in men and < 0.5 mg/dL in women; high: ≥ 0.6 mg/dL in men and ≥ 0.5 mg/dL in women.
‡ Ordinal values were assigned to coffee categories.
Wang et al. BMC Endocrine Disorders 2012, 12:24 Page 5 of 7
http://www.biomedcentral.com/1472-6823/12/24of bilirubin with HbA1c or type 2 diabetes mellitus does
not necessarily indicate a causal relationship because
hyperglycemia itself may decrease serum bilirubin due to
elevated oxidative stress [26]. The present findings add to
evidence that bilirubin is protective against deterioration
of glucose metabolism. Both bilirubin and GGT levels
increase in the presence of hepatobiliary diseases, but
bilirubin and GGT are generally uncorrelated with each
other in healthy subjects [27]. In the present study popu-
lation, bilirubin was weakly correlated with GGT only in
men.
In addition to a possible protective effect against type 2
diabetes mellitus [16,17], coffee has consistently been
shown to be associated with lower activities of serum
GGT [22]. Indeed, coffee consumption was strongly,
inversely associated with serum GGT in the present
study population as well [28]. Coffee did not affect the
association between GGT and HbA1c in either men or
women, and there was no tendency that coffee drinkers
had lower HbA1c concentrations when their GGT levels
were higher. The present findings are seemingly in dis-
agreement with the previous observation that a decreased
risk of type 2 diabetes mellitus associated with coffee
consumption was more marked in those with higher
levels of GGT [22]. However, the present study did not
address the association between coffee and the risk of
type 2 diabetes mellitus, and the findings do not neces-
sarily exclude the possibility that the risk of type 2 dia-
betes is decreased with coffee consumption in high
normal GGT levels.
The present study firstly addressed the association
between bilirubin and coffee in combination and HbA1c
concentrations. None has addressed the combined effect
of bilirubin and coffee on the risk of type 2 diabetes.
Because coffee and bilirubin are potent antioxidants, it
can be hypothesized that coffee’s effect on glucose metab-
olism may be modified by bilirubin status and vice versa.The inverse association between coffee consumption and
HbA1c observed among women with low bilirubin is
compatible with this hypothesis, but no such association
was observed in men. Careful interpretation is needed,
however, because the analysis on the combination of bili-
rubin and coffee included four statistical tests for the
trend (Table 3). There is a 15% chance that at least one of
the four P values will be 0.04 or less even if there is no
association between coffee and HbA1c. The combined
effect of bilirubin and coffee on glucose metabolism
would deserve further studies. It should be noted that
coffee may exert a protective effect on glucose metabol-
ism via mechanisms other than the antioxidant effect.
In vitro studies have suggested that antioxidant coffee
compounds such as chlorogenic acid and caffeic acid
delay glucose absorption in the intestine, inhibit glucose
output in the liver and increase peripheral glucose uptake
[29].
Although men consuming 1–3 cups of coffee per day
tended to have slightly lower concentrations of HbA1c,
those with the highest coffee consumption had rather
elevated HbA1c concentrations, especially when their
bilirubin was high. We have no prompt explanation for
the latter finding. The finding may be a chance fluctu-
ation because the number of such men was small, and
alternatively may be ascribed to residual confounding
factors which were not controlled for in the present
analysis.
In addition to a fairly large size of the study, some
advantages of the present study are noted. HbA1c and
bilirubin concentrations were uniformly measured, and
important confounders were taken into account. Several
weaknesses should be mentioned, however. Self-reported
coffee consumption suffers inaccuracy, causing measure-
ment misclassification. Causal inference is difficult for the
cross-sectional association, as discussed above. Comorbid
conditions may affect serum bilirubin concentrations and
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who had life-limiting morbid conditions such as athero-
sclerotic disease, cancer and liver disease. A low level of
participation (24%) in the survey is of another concern in
interpreting the results. Finally, it should be noted that
the measurement in the past year was used for GGT
among one-third of the subjects. Those having high GGT
levels before the survey may have been under treat-
ment for diabetes mellitus or prediabetic condition, and
thereby distorting the association between GGT and
HbA1c. In fact, the association between GGT and HbA1c
was slightly weaker among men, not among women, with
the past measurement of GGT than among men without.
The adjusted geometric means of HbA1c (%) for the
above-mentioned quartile categories of GGT were 5.00,
5.05, 5.14 and 5.15 respectively in men with the recorded
measurement (trend P < 10–5) and 4.98, 5.08, 5.18 and
5.28 respectively in men with GGT measurement at the
survey (trend P < 10–14). However, the analysis of the
subjects with GGT measurement at the survey showed
almost the same results as reported above with respect to
the associations with bilirubin and coffee and the effect
modifications of these covariates (data not shown).
Conclusions
In a large cross-sectional study of Japanese men and
women, a high level of serum bilirubin was consistently
associated with lower HbA1c concentrations across the
GGT levels. Coffee consumption was associated with
lower HbA1 concentrations in women, but not in men,
with a low bilirubin status. Bilirubin is possibly protect-
ive against deterioration of glucose metabolism. Further
studies are needed regarding the combined effect of bili-
rubin and coffee on glucose metabolism.
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